Lamivudine Therapy Exacerbates Bilirubinemia in Patients Underlying Severely Advanced Hepatitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2234-2753
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lamivudine Therapy Exacerbates Bilirubinemia in Patients Underlying Severely Advanced Hepatitis ; volume:33 ; number:4 ; day:1 ; month:10 ; year:2017 ; pages:343-350 ; date:10.2017
Toxicological research ; 33, Heft 4 (1.10.2017), 343-350, 10.2017
- Urheber
-
Choi, Young Hee
Lee, Chang Ho
Ko, Myong Suk
Han, Hyun Joo
Kim, Sang Geon
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.5487/TR.2017.33.4.343
- URN
-
urn:nbn:de:101:1-2021090420350299749212
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Choi, Young Hee
- Lee, Chang Ho
- Ko, Myong Suk
- Han, Hyun Joo
- Kim, Sang Geon
- SpringerLink (Online service)
Ähnliche Objekte (12)
Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
Lamivudine sensitivity - a case report
Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B
Mutation Pattern of Lamivudine Resistance in Relation to Hepatitis B Genotypes : Abhängigkeit zwischen Lamivudin induziertem Resistenzmuster und Hepatitis B Genotyp
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis
Immunstimulation bei Patienten mit chronischer Hepatitis B durch eine Kombination aus intradermaler Vakzine, Lamivudine und Interleukin-2
Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China
Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
Lamivudine sensitivity - a case report
Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B
Mutation Pattern of Lamivudine Resistance in Relation to Hepatitis B Genotypes : Abhängigkeit zwischen Lamivudin induziertem Resistenzmuster und Hepatitis B Genotyp
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis
Immunstimulation bei Patienten mit chronischer Hepatitis B durch eine Kombination aus intradermaler Vakzine, Lamivudine und Interleukin-2
Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China
Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
Lamivudine sensitivity - a case report
Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B
Mutation Pattern of Lamivudine Resistance in Relation to Hepatitis B Genotypes : Abhängigkeit zwischen Lamivudin induziertem Resistenzmuster und Hepatitis B Genotyp
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis
Immunstimulation bei Patienten mit chronischer Hepatitis B durch eine Kombination aus intradermaler Vakzine, Lamivudine und Interleukin-2